Abeona Therapeutics (ABEO) Short term Debt: 2011-2025
Historic Short term Debt for Abeona Therapeutics (ABEO) over the last 7 years, with Sep 2025 value amounting to $8.9 million.
- Abeona Therapeutics' Short term Debt rose 100.02% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 100.02%. This contributed to the annual value of $5.9 million for FY2024, which is N/A change from last year.
- According to the latest figures from Q3 2025, Abeona Therapeutics' Short term Debt is $8.9 million, which was up 59.99% from $5.6 million recorded in Q2 2025.
- Over the past 5 years, Abeona Therapeutics' Short term Debt peaked at $34.4 million during Q2 2021, and registered a low of $2.2 million during Q2 2024.
- For the 2-year period, Abeona Therapeutics' Short term Debt averaged around $5.9 million, with its median value being $5.7 million (2024).
- In the last 5 years, Abeona Therapeutics' Short term Debt crashed by 86.01% in 2022 and then skyrocketed by 150.05% in 2025.
- Abeona Therapeutics' Short term Debt (Quarterly) stood at $4.6 million in 2021, then plummeted by 75.39% to $4.9 million in 2022, then reached $5.9 million in 2024, then spiked by 100.02% to $8.9 million in 2025.
- Its Short term Debt stands at $8.9 million for Q3 2025, versus $5.6 million for Q2 2025 and $8.1 million for Q1 2025.